Analytical Data
-
基因名
TECTb
- Application
-
别名
TECTb；Beta-tectorin
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96PL2
-
表达区间
1-304aa
-
氨基酸序列
MVTKAFVLLA IFAEASAKSC APNKADVILV FCYPKTIITK IPECPYGWEV HQLALGGLCY NGVHEGGYYQ FVIPDLSPKN KSYCGTQSEY KPPIYHFYSH IVSNDTTVIV KNQPVNYSFS CTYHSTYLVN QAAFDQRVAT VHVKNGSMGT FESQLSLNFY TNAKFSIKKE APFVLEASEI GSDLFAGVEA KGLSIRFKVV LNSCWATPSA DFMYPLQWQL INKGCPTDET VLVHENGRDH RATFQFNAFR FQNIPKLSKV WLHCETFICD SEKLSCPVTC DKRKRLLRDQ TGGVLVVELS LRSR
-
分子量
34 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of TECTb recombinant protein is rooted in its significance within the field of molecular biology and immunology. TECTb, or T-cell extinction protein, has emerged as a critical focus due to its role in modulating immune responses and maintaining T-cell homeostasis. Abnormal expression or function of TECTb has been linked to various autoimmune diseases and cancers, prompting researchers to investigate its molecular mechanisms and biological implications. Recombinant protein technology allows for the effective production and purification of TECTb, facilitating detailed studies of its structure-function relationship. Understanding TECTb's interactions with other proteins and its signaling pathways can provide insights into how T-cell activation and regulation are controlled. Moreover, utilizing TECTb as a therapeutic target holds potential for developing innovative treatments for diseases characterized by immune dysregulation. As research progresses, the exploration of TECTb recombinant protein not only enhances our knowledge of T-cell biology but also opens new avenues for therapeutic interventions in immunological disorders.
